MissionIR Media is a news aggregator of MissionIR
June 13, 2025 8:45am
As inflationary pressures and elevated interest rates strain traditional financing channels, small and medium-sized businesses (“SMBs”) are increasingly seeking alternative funding sources to maintain liquidity and drive growth. Bank approval rates for SMB loans have dropped significantly – from 83% … Continue reading
June 12, 2025 12:07pm
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases. The company recently announced its financial results for the first quarter of 2025 as well as accomplishments representative of Soligenix’s continued commitment to advance … Continue reading
June 12, 2025 10:38am
FAVO Capital (OTC: FAVO) is developing a digital lending platform to address the persistent financing gap faced by underserved small and medium-sized businesses (“SMBs”). Traditional banks often deny credit to these businesses due to outdated underwriting models, creating a market ripe … Continue reading
June 12, 2025 8:45am
A wave of positive developments continues to build momentum for Nutriband (NASDAQ: NTRB), with recent capital funding, strategic partnerships and an expanded intellectual property portfolio reinforcing its bid to lead in the development of safer transdermal therapies. Nutriband is positioning itself … Continue reading
June 12, 2025 8:45am
In today’s increasingly fragile economic landscape, small and mid-sized businesses (“SMBs”) face mounting challenges in securing the funding necessary for growth and sustainability. Traditional banks, constrained by stringent regulations and risk-averse policies, often fall short in meeting the unique financial … Continue reading
June 12, 2025 8:10am
NRx Pharmaceuticals (NASDAQ: NRXP) and its wholly owned subsidiary HOPE Therapeutics, Inc. announced participation in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, set for June 16–17, 2025. Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx and Co-CEO … Continue reading
June 12, 2025 8:00am
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for NRX-100, a preservative-free formulation of ketamine. The submission seeks approval for all existing ketamine indications, including its use in … Continue reading
June 11, 2025 10:15am
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is moving forward … Continue reading
June 11, 2025 8:20am
Intelligent Bio Solutions (NASDAQ: INBS) reported continued growth in the U.S. Forensic Use Only Market through its strategic alliance with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX has deployed over 50 INBS Intelligent Fingerprinting Drug Screening … Continue reading
June 11, 2025 8:00am
Lantern Pharma (NASDAQ: LTRN) is a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing a pipeline of precision cancer therapies. … Continue reading
June 10, 2025 9:30am
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced that it … Continue reading
June 10, 2025 8:10am
Mullen Automotive (NASDAQ: MULN) has finalized a settlement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving all outstanding legal disputes. As part of the agreement, Mullen has transferred full ownership of its Mishawaka, Ind. manufacturing facility … Continue reading
June 10, 2025 8:00am
Newton Golf Company (NASDAQ: NWTG) announced the appointment of Jeff Clayborne as Chief Financial Officer, effective immediately. Clayborne brings over 30 years of financial leadership across consumer products, technology, and entertainment, including prior CFO roles at Perfect Moment (NYSE American: … Continue reading
June 09, 2025 8:00am
Nutriband (NASDAQ: NTRB) has been granted U.S. patent No. 12,318,492 for its “Abuse and Misuse Deterrent Transdermal Systems,” further strengthening domestic protection for its Aversa(TM) technology. The patent, issued June 3, 2025, enhances the company’s intellectual property portfolio for abuse-deterrent … Continue reading
June 06, 2025 2:45pm
Newton Golf Company (NASDAQ: NWTG) is riding the wave of golf’s renewed popularity, driven by increasing diversity, inclusivity, and innovation within the sport. With more than 47 million Americans engaging in golf activities in 2024, the sport has evolved into a … Continue reading
June 06, 2025 2:15pm
Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself for growth amid strong palladium market dynamics, driven by constrained supply and continued industrial demand. With palladium essential in automotive, electronics, and emerging clean energy applications, the company … Continue reading
June 06, 2025 12:58pm
Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, … Continue reading
June 06, 2025 11:00am
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, recently attended the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, continuing its push into the U.S. market for rapid, non-invasive screening … Continue reading
(512) 354-7000 | Copyright © . MissionIR Media. / Disclaimers